Annual balance sheet for Molecule, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.063 | 0.01 | 0 | 9.55 |
| Net Total Receivables | 0.004 | 0 | 0 | 0.493 |
| Total Current Assets | 0.067 | 0.011 | 0.001 | 10 |
| Net Property, Plant And Equipment | — | — | — | 0.003 |
| Total Assets | 0.067 | 0.011 | 0.001 | 10 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Total Current Liabilities | 0.09 | 0.108 | 0.123 | 0.365 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.09 | 0.108 | 0.123 | 0.365 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -0.023 | -0.097 | -0.123 | 9.68 |
| Total Liabilities & Shareholders' Equity | 0.067 | 0.011 | 0.001 | 10 |
| Total Common Shares Outstanding |